Clinical significance of E-cadherin and vimentin co-expression in breast cancer

International Journal of Oncology

Volumn 9, Issue 4, 1996, Pages 755-761

  Yagasaki, Ryo ^a   Noguchi, Masakuni ^a   Minami, Masahide ^a   Earashi, Mitsuharu ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

breast cancer; E cadherin; vimentin

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; BREAST CANCER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029794801     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.4.755     Document Type: Article

References (42)

1. Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A and Caldarola L: The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol 23: 849-854, 1987.
2. Lee YT and Chan LS: Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rate. J Surg Oncol 25: 102-108, 1984.
3. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lemer H, Margolese R, Poisson R, Shibata H, Volk H and other NSABP investigators: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983.
4. Noguchi M and Miyazaki I: Prognostic factors in breast cancer and their controversies (review). Oncol Rep 1: 1157-1163, 1994.
5. Fidler IJ: Origin and biology of cancer metastasis. Cytometry 10: 673-680, 1989.
6. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific sites. Biochim Biophys Acta 948: 175-224, 1988.
7. Poste G and Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139-146, 1980.
8. Liotta LA: Tumor invasion and metastases - role of the extracellular matrix: Rhoades memorial award lecture. Cancer Res 46: 1-7, 1986.
9. Liotta LA, Stetler-Stevenson WG and Steeg PS: Cancer invasion and metastases: positive and negative regulatory elements. Cancer Invest 9: 543-551, 1991.
10. Coman DR: Mechanism of the invasiveness of cancer. Science 105: 347-348, 1947.
11. McCutcheon M, Coman DR and Moore FB: Adhesiveness of malignant cells in various human adenocarcinomas. Cancer 1: 460-467, 1984.
12. Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP: Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 31: 325-335, 1994.
13. Harmer MH (ed): Union internationale contre le cancer: breast (ICD-0174). In: TMN Classification of Malignant Tumours. 4th edition. Springer-Verlag, Berlin, pp93-99, 1987.
14. Japan Breast Cancer Society: General rule for clinical and pathological record of breast cancer. 9th edition. Kanehara Co., Tokyo, pp21-29, 1988.
15. The World Health Organization: The World Health Organization histological typing of breast tumors. Am J Clin Pathol 78: 806-816, 1982.
16. Bloom HJG and Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-373, 1957.
17. Sato Y, Mukai K, Watanabe S, Goto M and Shimosato Y: The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 125: 431-435, 1986.
18. Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M and Cano A: Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142: 987-993, 1993.
19. Domagala W, Lasota J, Bartkowiak J, Weber K and Osborn M: Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 136: 219-227, 1990.
20. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G and Nakamura Y: Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184-7189, 1990.
21. Siozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, lihara K, Doki Y, Hirano S, Takeichi M and Mori T: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139: 17-23, 1991.
22. Graff JR, Herman JG, Lapidus RG, Chopra H, Xu R, Jarrard DF, Isaacs WB, Pitha PM, Davidson NE and Baylin SB: E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55: 5195-5199, 1995.
23. Eidelman S, Damsky CH, Wheelock MJ and Damjanov I: Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors. Am J Pathol 135: 101-110, 1989.
24. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M and Mon T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696-1701, 1993.
25. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS and Millis RR: Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169: 245-250, 1993.
26. Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991.
27. Behrens J, Marcel MM, Von Roy FM and Birchmeier W: Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447, 1989.
28. Leader M, Collins M, Patel J and Henry K: Vimentin: an evaluation of its role as a tumour maker. Histopathology 11: 63-72, 1987.
29. Azumi M and Battifora H: The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms: a comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Pathol 88: 286-296, 1987.
30. Gould VE: Histogenesis and differentiation: a re-evaluation of these concepts as criteria for the classification of tumors. Hum Pathol 17: 212-214, 1986.
31. Sommers CL, Walker-Jones D, Heckford SE, Worland P, Valverius E, Clark R, McCormick F, Stampfer M, Abularach S and Gelmann E: Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49: 4258-4263, 1989.
32. Thompson EW, Paik S, Brunner N, Sommers CL, Zugmaier G, Clarke R, Shima TB, Torri J, Donohue S, Lippman ME, Martin GR and Dickson RB: Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150: 534-544, 1992.
33. Bloemendal H and Pieper FR: Intermediate filaments: known structure, unknown function. Biochim Biophys Acta 1007: 245-253, 1989.
34. Raymond WA and Leong AS-Y: Vimentin - a new prognostic parameter in breast carcinoma? J Pathol 158: 107-114, 1989.
35. Heatley M, Whiteside C, Maxwell P and Toner P: Vimentin expression in benign and malignant breast epithelium. J Clin Pathol 46: 441-445, 1993.
36. Domagala W, Leszek W, Lasota J, Weber K and Osborn M: Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 137: 1059-1064, 1990.
37. Cattoretti G, Andreola S, Clemente C, D'Amato L and Rilke F: Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer 57: 353-357, 1988.
38. Grould VE, Kouloulis GK, Jansson DS, Nagle RB, Franke WW and Moll R: Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. Am J Pathol 137: 1143-1155, 1990.
39. Wada T, Yasutomi M, Hashimoto K, Kunikata M, Tanaka T and Mori M: Vimentin expression in benign and malignant lesions in the human mammary gland. Anticancer Res 12: 1973-1982, 1992.
40. Raymond WA and Leong AS-Y: Coexpression of cytokeratin and vimentin intermediate filament protein in benign and neoplastic breast epithelium. J Pathol 157: 299-306, 1989.
41. Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K and Osborn M: Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol 137: 1299-1304, 1990.
42. Sommers CL, Thompson EW, Torri JA, Kemler R, Geimann EP and Byers SW: Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Differ 2: 365-372, 1991.